FDA Inspection 1225663 — Rafarm S.A.
The FDA completed an inspection of Rafarm S.A. on May 19, 2023 in Paiania. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 19, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Paiania (Greece)
Additional Details
Bioanalytical BA/BE